Deborah Budge

TL;DR: The use of allografts with LVH in association with other high‐risk characteristics may result in increased mortality, and a subgroup analysis showed an increased risk of death in recipients of allogsraftsWith LVH and donor age >55 years, and in recipient of allogarafteds withLVH and ischemic time ≥4 h.

TL;DR: In patients with idiopathic dilated cardiomyopathy, placement of a Heartmate I ventricular assist device as a bridge to a cardiac transplant is associated with an elevation in the pretransplant panel-reactive antibody and a decrease in 1- and 5-year survivals after cardiac transplantation.

TL;DR: The impact of high‐dose inotropic donor support on early myocardial necrosis and outcomes in cardiac transplantation and the need for further research into this topic is investigated.

TL;DR: Using the silicone portion of the HMII driveline at the DLES was associated with fewer infections and a trend toward faster healing in this small retrospective series, which needs further study on a larger scale.

TL;DR: Patients with a right ventricular apical ICD lead placement that undergo placement of a HeartWare LVAD are susceptible to EMI and inappropriate ICD therapies, and patients that receive a Heart Ware LVAD with an ICD should have the device carefully checked at maximum LVAD output to determine if EMI may be present.